Effect of dietary vitamin E supplements on cholesteryl ester transfer activity in hamster adipose tissue.
Increased concentration of cholesteryl ester transfer protein (CETP) in plasma favours a lipoprotein profile characterized by a reduced high density lipoprotein (HDL) cholesterol. Previous studies have demonstrated that a diet high in cholesterol and saturated fat (HCSF) is associated with elevated plasma CETP and increased release of cholesterol ester transfer activity (CETA) from hamster adipose tissue incubated in vitro. The present study investigated the effects of vitamin E (Vit.E) ingestion on plasma CETP activity and adipose tissue CETA in Syrian Golden hamsters. A regular diet supplemented by the addition of 1% cholesterol and 10% coconut oil (w/w) was associated with a time-dependent increase in plasma CETP activity and increased release of adipose CETA following incubation of fragments of perirenal adipose tissue. Vit.E ingestion (100 mg/kg body weight per day for 8 weeks) suppressed 85% of the increase of CETA released from cultured hamster adipose tissue and 70% of the increase of plasma CETP activity induced by the HCSF diet. Significant decreases in plasma total and LDL cholesterol and an increase in HDL cholesterol were found in hamsters receiving the HCSF diet plus Vit.E compared to the animals on the HCSF diet alone. In the hamsters on regular chow, Vit.E ingestion alone did not significantly alter adipose tissue CETA, plasma CETP activity or plasma lipoproteins. The results indicate that Vit.E prevents the HCSF diet-induced increase in plasma CETP activity, probably via a reduction of CETA secretion from hamster adipose tissue. This suggests that Vit.E supplementation may help to ameliorate the dyslipidemia caused by a HCSF diet through its inhibitory influence on CETP production in adipose tissue.
Shen
G X
GX
Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.
Novak
C
C
Angel
A
A
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002352:Carrier Proteins / Q000097:blood / Q000187:drug effects* / Q000378:metabolism; D053480:Cholesterol Ester Transfer Proteins; D002791:Cholesterol, Dietary / Q000009:adverse effects; D003314:Corn Oil / Q000009:adverse effects; D006224:Cricetinae; D046508:Culture Techniques; D004305:Dose-Response Relationship, Drug; D005527:Food, Fortified; D006023:Glycoproteins; D008074:Lipoproteins / Q000097:blood / Q000187:drug effects; D008297:Male; D014810:Vitamin E / Q000008:administration & dosage*
D002352:Carrier Proteins; D053480:Cholesterol Ester Transfer Proteins; D002791:Cholesterol, Dietary; D006023:Glycoproteins; D008074:Lipoproteins; D014810:Vitamin E; D003314:Corn Oil